News | August 08, 2011

Edwards Lifesciences Launches Physio Tricuspid Heart Valve Repair Ring

August 8, 2011 – Edwards Lifesciences announced the global launch of the Carpentier-Edwards Physio Tricuspid Annuloplasty Ring for the treatment of tricuspid valve insufficiency. The company received both 510(k) clearance from the U.S. Food and Drug Administration (FDA) and CE mark for European sales of the device.

“Tricuspid valve insufficiency is a progressive disease that often leads to severe tricuspid regurgitation. When left untreated, it can affect patient outcomes and survival,” said Kevin Accola, M.D., thoracic and cardiovascular surgery, Florida Hospital Cardiovascular Institute. “This new treatment offers important therapeutic advancements, designed to allow surgeons to restore proper valve function with a ring that preserves natural movement and conforms to the shape of the valve annulus.” Accola provides paid consulting services to Edwards for training and education.

The ring features a three-dimensional waveform shape that allows it to conform to the natural shape of a patient's tricuspid valve opening, or annulus. It is also designed with “selective flexibility” to allow the native valve to maintain its natural movement. The ring also incorporates a number of ease-of-implant features, including a distinct sewing ledge that facilitates intuitive suture placement and alignment.

Severe tricuspid regurgitation is caused by the inability of the tricuspid valve leaflets to close properly, allowing the backward flow of blood.  Surgical repair with an annuloplasty repair ring is typically recommended for patients with significant dilation of the annulus. It is estimated that more than 100,000 patients suffer from tricuspid insufficiency annually in the United States.

For more information: www.edwards.com

Related Content

Appropriate Use Criteria Published for Valvular Heart Disease Imaging Tests
News | Clinical Decision Support| October 16, 2017
The American College of Cardiology (ACC), along with several partnering societies, recently released appropriate use...
Low Mortality and Stroke Risks Displayed for Minimally Invasive Aortic Valve Replacements
News | Heart Valve Technology| October 11, 2017
An analysis of more than 1,000 minimally invasive aortic valve replacements and more than 400 additional associated...
Medtronic Announces Post-Market Study for CoreValve Evolut Pro System
News | Heart Valve Technology| October 02, 2017
Medtronic plc recently announced a new post-market clinical study to evaluate its CoreValve Evolut Pro valve in...
Montreal Heart Institute Performs First Robotic Mitral Valve Surgery
News | Robotic Systems| September 22, 2017
The Montreal Heart Institute (MHI) announced the acquisition of the da Vinci Xi, a new-generation surgical robot, and...
Edwards Inspiris Resilia Valve Receives FDA Approval
News | Heart Valve Technology| September 21, 2017
Edwards Lifesciences Corp. recently received U.S. Food and Drug Administration (FDA) approval for its Inspiris Resilia...
Gecko Biomedical Receives CE Mark Approval for Setalum Sealant
News | Cardiovascular Surgery| September 19, 2017
Gecko Biomedical announced it has received CE Mark approval for its Setalum Sealant, allowing the company to market its...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
TCT 2017 late-breaking trials and studies that will be presented on the latest cardiology technology clinical trials.
Feature | September 11, 2017
September 11, 2017 — From numerous high-quality submissions, Transcatheter Cardiovascular Therapeutics (TCT) has sele
ClearFlow Inc. Announces Positive U.S. Clinical Trial Results
News | Cardiovascular Surgery| September 08, 2017
September 8, 2017 — ClearFlow Inc.
Overlay Init